Dorsey & Whitney Trust CO LLC Cuts Holdings in LHC Group (LHCG)
Dorsey & Whitney Trust CO LLC decreased its position in LHC Group (NASDAQ:LHCG) by 20.5% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 3,225 shares of the health services provider’s stock after selling 833 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in LHC Group were worth $219,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Ameriprise Financial Inc. lifted its stake in LHC Group by 6.7% in the 2nd quarter. Ameriprise Financial Inc. now owns 578,956 shares of the health services provider’s stock valued at $39,306,000 after acquiring an additional 36,218 shares in the last quarter. TIAA CREF Investment Management LLC lifted its stake in LHC Group by 27.1% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 161,596 shares of the health services provider’s stock valued at $10,971,000 after acquiring an additional 34,451 shares in the last quarter. Teachers Advisors LLC lifted its stake in LHC Group by 6.6% in the 2nd quarter. Teachers Advisors LLC now owns 44,384 shares of the health services provider’s stock valued at $3,013,000 after acquiring an additional 2,742 shares in the last quarter. AJO LP bought a new stake in LHC Group in the 2nd quarter valued at approximately $6,300,000. Finally, Martingale Asset Management L P lifted its stake in LHC Group by 44.3% in the 2nd quarter. Martingale Asset Management L P now owns 35,504 shares of the health services provider’s stock valued at $2,411,000 after acquiring an additional 10,903 shares in the last quarter. Hedge funds and other institutional investors own 85.93% of the company’s stock.
Shares of LHC Group (NASDAQ:LHCG) opened at 65.57 on Friday. The company has a market cap of $1.20 billion, a PE ratio of 29.01 and a beta of 0.76. The stock’s 50 day moving average price is $63.46 and its 200-day moving average price is $59.66. LHC Group has a 52 week low of $32.04 and a 52 week high of $69.35.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. During the same quarter last year, the company earned $0.52 earnings per share. The company’s revenue for the quarter was up 15.1% on a year-over-year basis. Analysts expect that LHC Group will post $2.39 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Dorsey & Whitney Trust CO LLC Cuts Holdings in LHC Group (LHCG)” was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/17/dorsey-whitney-trust-co-llc-cuts-holdings-in-lhc-group-lhcg.html.
Several equities research analysts have commented on the company. Robert W. Baird restated a “hold” rating and issued a $63.00 target price on shares of LHC Group in a research note on Tuesday, September 12th. Royal Bank Of Canada reiterated a “buy” rating and set a $70.00 price objective on shares of LHC Group in a research note on Wednesday, September 6th. Bank of America Corporation assumed coverage on LHC Group in a research note on Monday, August 21st. They set a “buy” rating and a $76.00 price objective on the stock. BidaskClub upgraded LHC Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $68.00 price objective on shares of LHC Group in a research note on Friday, August 4th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. LHC Group currently has an average rating of “Buy” and a consensus target price of $66.60.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.80% of the stock is owned by company insiders.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.